161 related articles for article (PubMed ID: 11440277)
1. Octreotide reduces vitreous hemorrhage and loss of visual acuity risk in patients with high-risk proliferative diabetic retinopathy.
Boehm BO; Lang GK; Jehle PM; Feldman B; Lang GE
Horm Metab Res; 2001 May; 33(5):300-6. PubMed ID: 11440277
[TBL] [Abstract][Full Text] [Related]
2. [Results of laser photocoagulation in patients with diabetic retinopathy developed as a complication of diabetes type 2].
Wilczyński M; Dzivgielewski K
Klin Oczna; 2006; 108(1-3):66-9. PubMed ID: 16883944
[TBL] [Abstract][Full Text] [Related]
3. Effect of ruboxistaurin on visual loss in patients with diabetic retinopathy.
; Aiello LP; Davis MD; Girach A; Kles KA; Milton RC; Sheetz MJ; Vignati L; Zhi XE
Ophthalmology; 2006 Dec; 113(12):2221-30. PubMed ID: 16989901
[TBL] [Abstract][Full Text] [Related]
4. Red krypton and blue-green argon panretinal laser photocoagulation for proliferative diabetic retinopathy: a laboratory and clinical comparison.
Blankenship GW
Trans Am Ophthalmol Soc; 1986; 84():967-1003. PubMed ID: 2438841
[TBL] [Abstract][Full Text] [Related]
5. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
Luttrull JK; Musch DC; Spink CA
Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
[TBL] [Abstract][Full Text] [Related]
6. [Timing of vitrectomy for proliferative diabetic retinopathy in cases with type II diabetes mellitus].
Li X; Jiang Y; Ye C; Li C
Zhonghua Yan Ke Za Zhi; 1999 Mar; 35(2):116-8. PubMed ID: 11835788
[TBL] [Abstract][Full Text] [Related]
7. Photocoagulation in diabetic retinopathy. A multicentre study in Sweden.
Stenkula S
Acta Ophthalmol Suppl; 1984; 162():1-100. PubMed ID: 6324526
[TBL] [Abstract][Full Text] [Related]
8. [Cryocoagulation in therapy of proliferative diabetic retinopathy].
Pauleikhoff D; Engineer B; Wessing A
Klin Monbl Augenheilkd; 1997 Mar; 210(3):147-52. PubMed ID: 9206746
[TBL] [Abstract][Full Text] [Related]
9. Visual outcome and risk factors for light perception and no light perception vision after vitrectomy for diabetic retinopathy.
Mason JO; Colagross CT; Haleman T; Fuller JJ; White MF; Feist RM; Emond TL; McGwin G
Am J Ophthalmol; 2005 Aug; 140(2):231-5. PubMed ID: 15992755
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone suppression and nonproliferative diabetic retinopathy: a preliminary feasibility study.
Shumak SL; Grossman LD; Chew E; Kozousek V; George SR; Singer W; Harris AG; Zinman B
Clin Invest Med; 1990 Oct; 13(5):287-92. PubMed ID: 2276223
[TBL] [Abstract][Full Text] [Related]
11. Management of proliferative diabetic retinopathy.
Gündüz K; Bakri SJ
Compr Ophthalmol Update; 2007; 8(5):245-56. PubMed ID: 18201511
[TBL] [Abstract][Full Text] [Related]
12. Diabetic retinopathy. Screening and prevention of blindness. A doctoral thesis.
Kristinsson JK
Acta Ophthalmol Scand Suppl; 1997; (223):1-76. PubMed ID: 9559048
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal triamcinolone as an adjunct to standard laser therapy in coexisting high-risk proliferative diabetic retinopathy and clinically significant macular edema.
Mirshahi A; Shenazandi H; Lashay A; Faghihi H; Alimahmoudi A; Dianat S
Retina; 2010 Feb; 30(2):254-9. PubMed ID: 20057344
[TBL] [Abstract][Full Text] [Related]
14. [Effect of argon laser photocoagulation on diabetic retinopathy].
Wei ZY; Hu SX; Tang N; Wu J; Wang J
Di Yi Jun Yi Da Xue Xue Bao; 2004 Nov; 24(11):1313-5. PubMed ID: 15567792
[TBL] [Abstract][Full Text] [Related]
15. The effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
Henricsson M; Nilsson A; Janzon L; Groop L
Diabet Med; 1997 Feb; 14(2):123-31. PubMed ID: 9047089
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
Sutter FK; Simpson JM; Gillies MC
Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal long-acting gas in the prevention of early postoperative vitreous hemorrhage in diabetic vitrectomy.
Yang CM; Yeh PT; Yang CH
Ophthalmology; 2007 Apr; 114(4):710-5. PubMed ID: 17275908
[TBL] [Abstract][Full Text] [Related]
18. [Value of different measurements of the preoperative visual acuity and perception of Purkinje's vessel shadows for prediction of the postoperative visual acuity after vitrectomy in diabetic vitreous hemorrhage].
Schulze S; Köhler K; Schüller C
Klin Monbl Augenheilkd; 2006 Apr; 223(4):321-5. PubMed ID: 16639671
[TBL] [Abstract][Full Text] [Related]
19. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
[TBL] [Abstract][Full Text] [Related]
20. [Influence of membrane dissection and en bloc excision on the outcome of vitreous surgery in proliferative diabetic retinopathy].
Li XX; Jiang YR; Yin H; Zhao MW
Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):439-42. PubMed ID: 15454056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
